Oral p38 Mitogen-Activated Protein Kinase Inhibition With BIRB 796 for Active Crohn’s Disease: A Randomized, Double-Blind, Placebo-Controlled Trial

2006 ◽  
Vol 4 (3) ◽  
pp. 325-334 ◽  
Author(s):  
Stefan Schreiber ◽  
Brian Feagan ◽  
Geert D’Haens ◽  
Jean–Frederic Colombel ◽  
Karel Geboes ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Protein Kinase ◽  
Crohn's Disease ◽  
Controlled Trial ◽  
Mitogen Activated Protein Kinase ◽  
Double Blind ◽  
Kinase Inhibition ◽  
Double Blind Placebo ◽  
Protein Kinase Inhibition ◽  
Mitogen Activated Protein

scholarly journals Tu1716 – Highly Bioavailable Curcumin (Theracurmin®) for Crohn's Disease: Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial

2019 ◽  
Vol 156 (6) ◽  
pp. S-1096 ◽  
Author(s):  
Ken Sugimoto ◽  
Kentaro Ikeya ◽  
Shigeki Bamba ◽  
Akira Andoh ◽  
Hiroshi Yamasaki ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo

Mitogen-activated protein kinase inhibition reduces mucin 2 production and mucinous tumor growth

2015 ◽  
Vol 166 (4) ◽  
pp. 344-354 ◽  
Author(s):  
Ashok K. Dilly ◽  
Xinxin Song ◽  
Herbert J. Zeh ◽  
Zong S. Guo ◽  
Yong J. Lee ◽  
...  
Keyword(s):  
Protein Kinase ◽  
Tumor Growth ◽  
Mitogen Activated Protein Kinase ◽  
Mucinous Tumor ◽  
Kinase Inhibition ◽  
Protein Kinase Inhibition ◽  
Mitogen Activated Protein ◽  
Mucin 2

scholarly journals Double blind, placebo controlled trial of metronidazole in Crohn's disease.

Gut ◽  
1991 ◽  
Vol 32 (9) ◽  
pp. 1071-1075 ◽  
Author(s):  
L Sutherland ◽  
J Singleton ◽  
J Sessions ◽  
S Hanauer ◽  
E Krawitt ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo
Sign in / Sign up

Export Citation Format

Share Document